Related references
Note: Only part of the references are listed.To SMILE or Not: Supportive Care Matters
Alexandre Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Arnaud Jaccard et al.
BLOOD (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas
Winnie K. S. Chan et al.
CLINICAL NUCLEAR MEDICINE (2010)
Diagnosis and management of natural killer-cell malignancies
Fumihiro Ishida et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies
Y. -L Kwong
BONE MARROW TRANSPLANTATION (2009)
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Seok Jin Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
Motoko Yamaguchi et al.
CANCER SCIENCE (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
J Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients
WY Au et al.
BLOOD (2004)
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
CS Chim et al.
BLOOD (2004)
L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma
WB Yong et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Share Paper
